[(WR)<sub>8</sub>WKβA]-Doxorubicin Conjugate: A Delivery System to Overcome Multi-Drug Resistance against Doxorubicin

Doxorubicin (Dox) is an anthracycline chemotherapeutic agent used to treat breast, leukemia, and lymphoma malignancies. However, cardiotoxicity and inherent acquired resistance are major drawbacks, limiting its clinical application. We have previously shown that cyclic peptide [WR]<sub>9</s...

Full description

Bibliographic Details
Published in:Cells
Main Authors: Khalid Zoghebi, Hamidreza Montazeri Aliabadi, Rakesh Kumar Tiwari, Keykavous Parang
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Subjects:
antiproliferative
cancer
Doxorubicin
endocytosis
resistance
Online Access:https://www.mdpi.com/2073-4409/11/2/301

Internet

https://www.mdpi.com/2073-4409/11/2/301

Similar Items